The University of New Mexico Center for Molecular Discovery

ISSN: 1875-5402 (Online)
ISSN: 1386-2073 (Print)


Volume 17, 10 Issues, 2014


Download PDF Flyer




Combinatorial Chemistry & High Throughput Screening

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 23rd of 71 in Chemistry, Applied

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Rathnam Chaguturu
iDDPartners, 3 Edith Court
Princeton Junction
NJ 08550
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.925
5 - Year: 1.782

The University of New Mexico Center for Molecular Discovery

Author(s): Bruce S. Edwards, Kristine Gouveia, Tudor I Oprea and Larry A. Sklar

Affiliation: Center for Molecular Discovery, Innovation Discovery and Training Center, Health Sciences Center, University of New Mexico, Albuquerque, NM 87131, USA.

Abstract

The University of New Mexico Center for Molecular Discovery (UNMCMD) is an academic research center that specializes in discovery using high throughput flow cytometry (HTFC) integrated with virtual screening, as well as knowledge mining and drug informatics. With a primary focus on identifying small molecules that can be used as chemical probes and as leads for drug discovery, it is a central core resource for research and translational activities at UNM that supports implementation and management of funded screening projects as well as "up-front" services such as consulting for project design and implementation, assistance in assay development and generation of preliminary data for pilot projects in support of competitive grant applications. The HTFC platform in current use represents advanced, proprietary technology developed at UNM that is now routinely capable of processing bioassays arrayed in 96-, 384- and 1536-well formats at throughputs of 60,000 or more wells per day. Key programs at UNMCMD include screening of research targets submitted by the international community through NIH's Molecular Libraries Program; a multi-year effort involving translational partnerships at UNM directed towards drug repurposing - identifying new uses for clinically approved drugs; and a recently established personalized medicine initiative for advancing cancer therapy by the application of "smart" oncology drugs in selected patients based on response patterns of their cancer cells in vitro. UNMCMD discoveries, innovation, and translation have contributed to a wealth of inventions, patents, licenses and publications, as well as startup companies, clinical trials and a multiplicity of domestic and international collaborative partnerships to further the research enterprise.

Keywords: 1536-well format, Hypercyt, drug discovery, drug repurposing, personalized medicine, efflux pumps, GTPases, high throughput flow cytometry, NMMLSC, phenotypic screening.

Download Free Rights and Permissions

  
  



Article Details

Volume: 17
Issue Number: 3
First Page: 256
Last Page: 265
Page Count: 10
DOI: 10.2174/1386207317666140109123908
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science